A Retrospective, Observational study to evaluate real-world patient outcomes associated with Pembrolizumab for advanced Melanoma
Latest Information Update: 25 Jun 2018
At a glance
- Drugs Pembrolizumab (Primary)
- Indications Malignant melanoma
- Focus Therapeutic Use
- 25 Jun 2018 New trial record
- 05 Jun 2018 Results comparing real-world outcomes of pembrolizumab with that of KEYNOTE-006, presented at the 54th Annual Meeting of the American Society of Clinical Oncology